H1 2019 Life Sciences Software Market Update

Madison Park Group (MPG) actively tracks the life sciences software landscape and has been instrumental in strategic deals across the drug development & commercial spectrum.

Through MPG’s time in the space, we’ve noticed a number of trends and developments:

• Virtual clinical trial applications are gaining significant traction as organizations aim to increase the efficiency of patient recruiting

• Artificial intelligence (AI) and machine learning (ML) applications continue to pour into the life science industry, attracting high-profile, early-stage investments

• Multiple large acquisitions and aggressive sponsor buyout activity illustrates bullish buyer views of the life science software market

• Pharma IT spend will accelerate as a result of continuous development of novel therapies, changing policies in insurance and pricing, and an ongoing need for operational efficiency